Literature DB >> 1510381

Iron regulation in the brain: histochemical, biochemical, and molecular considerations.

J R Connor1, S A Benkovic.   

Abstract

Despite recognition that iron is important for normal neurological function, the proteins involved in maintaining iron homeostasis within the brain have until recently received little attention. In the past few years, studies aimed at determining both general and cellular control of iron in the brain have increased. Histological studies indicate that maintenance of iron homeostasis in the brain is the responsibility of neuroglia and possibly the choroid plexus. Transferrin, the iron transport protein, has been found predominantly in oligodendrocytes in the brain and in myelinating Schwann cells in the peripheral nervous system. The messenger RNA for transferrin is located in the brain in oligodendrocytes and the choroid plexus. Most of the transferrin protein and transcript expression in the brain is dependent on the presence of a mature population of oligodendrocytes. Transferrin is also involved in the transport of iron across the blood-brain barrier via transferrin receptors on brain capillary endothelial cells. The transferrin receptor is also present on cells within the brain. Ferritin, the iron storage protein, and iron are found in the brain in oligodendrocytes and microglia. Additional cells in which iron and ferritin are found are tanycytes, which are associated with the third ventricle. This latter observation raises interesting possibilities regarding the transport of iron from cerebrospinal fluid into the brain. The high iron requirement of the brain coupled with the high susceptibility of the brain to iron-generated peroxidative damage requires stringent regulation of the availability of iron. Consequently, the iron regulatory proteins are central to understanding mechanisms controlling iron-dependent activity at the cellular level, as well as protection of the brain from oxidative damage. The behavior of brain iron regulatory proteins will be a significant factor in future studies of the neurological diseases resulting from brain iron imbalance. We review the contributions of our laboratory to this field over the past 6 years, discuss current projects, and suggest future directions for study.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1510381     DOI: 10.1002/ana.410320710

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  35 in total

Review 1.  Toxicology of choroid plexus: special reference to metal-induced neurotoxicities.

Authors:  W Zheng
Journal:  Microsc Res Tech       Date:  2001-01-01       Impact factor: 2.769

2.  p53-independent inhibition of proliferation and p21(WAF1/Cip1)-modulated induction of cell death by the antioxidants N-acetylcysteine and vitamin E.

Authors:  J L Nargi; R R Ratan; D E Griffin
Journal:  Neoplasia       Date:  1999-12       Impact factor: 5.715

3.  Ceruloplasmin gene expression in the murine central nervous system.

Authors:  L W Klomp; Z S Farhangrazi; L L Dugan; J D Gitlin
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

4.  Iron fortified follow on formula from 9 to 18 months improves iron status but not development or growth: a randomised trial.

Authors:  R Morley; R Abbott; S Fairweather-Tait; U MacFadyen; T Stephenson; A Lucas
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

5.  Test-retest reliability and concurrent validity of in vivo myelin content indices: Myelin water fraction and calibrated T1 w/T2 w image ratio.

Authors:  Muzamil Arshad; Jeffrey A Stanley; Naftali Raz
Journal:  Hum Brain Mapp       Date:  2016-12-23       Impact factor: 5.038

6.  Gestational and lactational iron deficiency alters the developing striatal metabolome and associated behaviors in young rats.

Authors:  Kay L Ward; Ivan Tkac; Yuezhou Jing; Barbara Felt; John Beard; James Connor; Timothy Schallert; Michael K Georgieff; Raghavendra Rao
Journal:  J Nutr       Date:  2007-04       Impact factor: 4.798

Review 7.  Brain barrier systems: a new frontier in metal neurotoxicological research.

Authors:  Wei Zheng; Michael Aschner; Jean-Francois Ghersi-Egea
Journal:  Toxicol Appl Pharmacol       Date:  2003-10-01       Impact factor: 4.219

8.  Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications.

Authors:  George Bartzokis; Po H Lu; Todd A Tishler; Sophia M Fong; Bolanle Oluwadara; J Paul Finn; Danny Huang; Yvette Bordelon; Jim Mintz; Susan Perlman
Journal:  Neurochem Res       Date:  2007-05-05       Impact factor: 3.996

9.  Enhanced phosphatidylinositol 3-kinase (PI3K)/Akt signaling has pleiotropic targets in hippocampal neurons exposed to iron-induced oxidative stress.

Authors:  Romina María Uranga; Sebastián Katz; Gabriela Alejandra Salvador
Journal:  J Biol Chem       Date:  2013-05-16       Impact factor: 5.157

Review 10.  Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders.

Authors:  P J Syapin
Journal:  Br J Pharmacol       Date:  2008-09-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.